Norges Bank’s Inovio Pharmaceuticals INO Stock Holding History

Norges Bank’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-116,900	Closed	-$2.43M	–	2108
2022 Q2	$2.43M	Hold	116,900	–	–	﹤0.01%	1879
2022 Q1	$5.04M	Hold	116,900	–	–	﹤0.01%	1869
2021 Q4	$7M	Hold	116,900	–	–	﹤0.01%	1851
2021 Q3	$10M	Buy	116,900 +12,338	+12%	+$1.24M	﹤0.01%	1763
2021 Q2	$11.6M	Hold	104,562	–	–	﹤0.01%	1738
2021 Q1	$11.6M	Sell	104,562 -21,877	-17%	-$2.88M	﹤0.01%	1749
2020 Q4	$13.4M	Buy	126,439 +7,734	+7%	+$1.03M	﹤0.01%	1691
2020 Q3	$16.5M	Buy	+118,705	New	+$24.8M	﹤0.01%	1540

Other funds holding INO

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Norges Bank's INO Position: Q3 2022 in Review

Norges Bank sold out of Inovio Pharmaceuticals (INO) in Q3 2022, closing a stake of 116,900 shares — an estimated $2.43M sold.

Norges Bank first reported a position in INO in Q3 2020 and held it in 8 quarters. The position peaked at $16.5M in Q3 2020. 182 funds tracked by Wall St. Rank hold INO as of Q3 2022.

Norges Bank reported no remaining Inovio Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Norges Bank sold 116,900 Inovio Pharmaceuticals shares in Q3 2022, an estimated $2.43M.
Norges Bank first reported a position in Inovio Pharmaceuticals in Q3 2020 and held it in 8 quarters.
Norges Bank's Inovio Pharmaceuticals position peaked at $16.5M in Q3 2020.
182 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2022.

Based on Norges Bank's 13F filing for Q3 2022, filed 14 Nov 2022.